GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Edap TMS SA (NAS:EDAP) » Definitions » COGS-to-Revenue

Edap TMS (Edap TMS) COGS-to-Revenue : 0.56 (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Edap TMS COGS-to-Revenue?

Edap TMS's Cost of Goods Sold for the three months ended in Dec. 2023 was $12.05 Mil. Its Revenue for the three months ended in Dec. 2023 was $21.39 Mil.

Edap TMS's COGS to Revenue for the three months ended in Dec. 2023 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Edap TMS's Gross Margin % for the three months ended in Dec. 2023 was 43.66%.


Edap TMS COGS-to-Revenue Historical Data

The historical data trend for Edap TMS's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edap TMS COGS-to-Revenue Chart

Edap TMS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.53 0.56 0.58 0.56 0.60

Edap TMS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.59 0.60 0.65 0.56

Edap TMS COGS-to-Revenue Calculation

Edap TMS's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=39.271 / 65.892
=0.60

Edap TMS's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=12.051 / 21.388
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Edap TMS  (NAS:EDAP) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Edap TMS's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 12.051 / 21.388
=43.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Edap TMS COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Edap TMS's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Edap TMS (Edap TMS) Business Description

Traded in Other Exchanges
Address
Parc d'Activites La Poudrette-Lamartine, 4/6, rue du Dauphine, Vaulx-en-Velin, FRA, 69120
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.